ABSTRACT
Recent approvals of long-acting (LA) antiretroviral treatment (ART) support an innovative alternative to daily oral pills that can improve adherence and treatment outcomes among adolescents and youth (AY) with HIV. We solicited stakeholder feedback on the implementation of LA ART for AY in low-and middle-income countries (LMICs) through a consensus-building forum at the 2022 International Workshop on HIV and Adolescence.
We used the nominal group technique to generate, record, discuss, vote on, and rank perceived barriers and facilitators to implementing LA ART for AY. All in-person attendees were invited to participate and were assigned to six groups, each representing an intentional mix of AY, clinicians, researchers, program implementers and policymakers. We collected self-reported de-identified demographics and group rankings of barriers and facilitators. Responses were coded and categorized using the social-ecological model’s five levels of influence.
137 Workshop delegates (67.9% male, 27.7% female; 0.7% non-binary and 46.7% less than 35 years old) participated in the group discussions. A large proportion of participants (51.9%) reported working in public health/program implementation. Most participants (88.4%) were from and/or worked in the African region. We identified 55 barriers and 48 facilitators of LA ART implementation and ranked them in social-ecological model categories of public policy, community, institutional/organizational, interpersonal, and individual levels. The highest number of ranked barriers was at the institutional/organizational level. The themes of “equitable access” and “choices of ART” were cross-cutting across individual and interpersonal levels. Other cross-cutting themes were “cost of LA ART” and “need for funding and sustainability of LA ART programs”. Proposed facilitators addressed identified barriers at each social-ecological level of influence and emphasized peer engagement.
Our nominal groups identified key barriers and proposed facilitators at five different social ecological levels, which can inform implementation science-guided design and equitable implementation of youth centered LA ART in LMICs and globally.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Johnson and Johnson Pharmaceuticals funded the facilitation of the nominal group session, but had no role in design, participant recruitment, data collection, nor the conceptualization, development or writing of this article.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail addresses of authors: NASA: nsamagudu{at}ihvnigeria.org CA: cadirieje{at}ihvnigeria.org ALA: ageorg10{at}jhmi.edu NR: NRakhman{at}childrensnational.org
Data Availability
All of the data collected is provided in the manuscript and supporting materials.
